These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 17267466)

  • 1. Unicentric and multicentric Castleman's disease.
    Enomoto K; Nakamichi I; Hamada K; Inoue A; Higuchi I; Sekimoto M; Mizuki M; Hoshida Y; Kubo T; Aozasa K; Hatazawa J
    Br J Radiol; 2007 Jan; 80(949):e24-6. PubMed ID: 17267466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PET/CT findings in a multicentric form of Castleman's disease.
    Halac M; Ergul N; Sager S; Demir A; Buyukpinarbasli N; Sonmezoglu K
    Hell J Nucl Med; 2007; 10(3):172-4. PubMed ID: 18084659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FDG PET/CT appearance of multicentric Castleman's disease mimicking lymphoma.
    Elboga U; Narin Y; Urhan M; Sahin E
    Rev Esp Med Nucl Imagen Mol; 2012; 31(3):142-4. PubMed ID: 22133346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FDG-PET appearance of pelvic Castleman's disease.
    Murphy SP; Nathan MA; Karwal MW
    J Nucl Med; 1997 Aug; 38(8):1211-2. PubMed ID: 9255152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Fortuitous diagnosis of Castleman's disease by FDG-PET Scan during the follow-up of a renal cancer patient].
    Italiano A; Butori C; Verge M; Mouroux J; Thyss A
    Rev Med Interne; 2005 Jul; 26(7):597-9. PubMed ID: 15996575
    [No Abstract]   [Full Text] [Related]  

  • 6. Metabolic characteristics of Castleman disease on 18F-FDG PET in relation to clinical implication.
    Lee ES; Paeng JC; Park CM; Chang W; Lee WW; Kang KW; Chung JK; Lee DS
    Clin Nucl Med; 2013 May; 38(5):339-42. PubMed ID: 23429387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The spectrum of Castleman's disease: mimics, radiologic pathologic correlation and role of imaging in patient management.
    Madan R; Chen JH; Trotman-Dickenson B; Jacobson F; Hunsaker A
    Eur J Radiol; 2012 Jan; 81(1):123-31. PubMed ID: 20643523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FDG-PET and diffusion-weighted MR imaging appearance in retroperitoneal Castleman's disease: a case report.
    Oida Y; Shimizu K; Mukai M; Imaizumi T; Nakamura M; Makuuchi H
    Clin Imaging; 2008; 32(2):144-6. PubMed ID: 18313580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Imaging findings of angiofollicular lymphoid hyperplasia (Castleman's disease)].
    Horger M; Bares R; Wiefels J; Schöber W; Müssig K
    Rofo; 2007 Oct; 179(10):991-6. PubMed ID: 18240398
    [No Abstract]   [Full Text] [Related]  

  • 10. FDG positron emission tomographic imaging of thoracic Castleman's disease.
    Reddy MP; Graham MM
    Clin Nucl Med; 2003 Apr; 28(4):325-6. PubMed ID: 12642717
    [No Abstract]   [Full Text] [Related]  

  • 11. Follicular dendritic sarcoma within a focus of Castleman's disease. Serial FDG PET/CT in the follow up of recurrence with histopathologic confirmation.
    Iagaru A; Mari C; Sam Gambhir S
    Rev Esp Med Nucl; 2007; 26(1):40-5. PubMed ID: 17286947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 18F-FDG PET/CT in the evaluation of POEMS syndrome.
    Albertí MA; Martinez-Yélamos S; Fernandez A; Vidaller A; Narváez JA; Cano LM; Gamez C; Martinez-Matos JA
    Eur J Radiol; 2010 Nov; 76(2):180-2. PubMed ID: 19581061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FDG-PET/CT imaging in the management of HIV-associated multicentric Castleman's disease.
    Barker R; Kazmi F; Stebbing J; Ngan S; Chinn R; Nelson M; O'Doherty M; Bower M
    Eur J Nucl Med Mol Imaging; 2009 Apr; 36(4):648-52. PubMed ID: 19050873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FDG-PET/ CT for initial staging and response assessment in Castleman disease - retrospective single-center study of 29 cases.
    Koukalová R; Selingerová I; Řehák Z; Adam Z; Szturz P
    Klin Onkol; 2021; 34(2):120-127. PubMed ID: 33906360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Focal bone marrow involvement in multicentric castleman disease demonstrated by FDG PET/CT.
    Ramos CD; Massumoto CM; Rosa MF; Mazo-Ruiz MF; Mitteldorf C; Etchebehere EC; Santos AO; Lima MC; Cerri GG; Camargo EE
    Clin Nucl Med; 2007 Apr; 32(4):295-6. PubMed ID: 17413577
    [No Abstract]   [Full Text] [Related]  

  • 16. [The application of 18F-fluorodeoxyglucose positron emission tomography in the diagnosis and staging of lung cancer].
    Xu HF; Liu Y; Zhang JH; Zhou RS; Zhou FH; Yuan MH
    Zhonghua Jie He He Hu Xi Za Zhi; 2005 Feb; 28(2):108-11. PubMed ID: 15854393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Castleman's disease in the head and neck region: Meta-analysis of reported cases in Taiwan and literature review.
    Lin CY; Chang YL
    J Formos Med Assoc; 2010 Dec; 109(12):913-20. PubMed ID: 21195890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Castleman's disease of the parotid gland: a case report.
    Gürbüzler L; Ceylan A; Yilmaz M; Vural C
    Kaohsiung J Med Sci; 2010 Aug; 26(8):444-7. PubMed ID: 20705256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Unusual Presentation of Multiple Sclerotic Bone Lesions in Unicentric Castleman's Disease.
    Balapanga S; Kalyan Kumar Reddy A; D J S; Thirupathi MSV
    Cureus; 2024 Jul; 16(7):e63738. PubMed ID: 39100061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The characterization and management of Castleman's disease.
    Zhou N; Huang CW; Huang C; Liao W
    J Int Med Res; 2012; 40(4):1580-8. PubMed ID: 22971511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.